Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants
View/ Open
Volume
13
Publisher
DOI
10.3390/genes13040697
Journal
Genes (Basel)
Issue
Metadata
Show full item recordAbstract
Background: Detecting pathogenic intronic variants resulting in aberrant splicing remains a challenge in routine genetic testing. We describe germline whole-exome sequencing (WES) analyses and apply in silico predictive tools of familial ovarian cancer (OC) cases reported clinically negative for pathogenic BRCA1 and BRCA2 variants. Methods: WES data from 27 familial OC cases reported clinically negative for pathogenic BRCA1 and BRCA2 variants and 53 sporadic early-onset OC cases were analyzed for pathogenic variants in BRCA1 or BRCA2. WES data from carriers of pathogenic BRCA1 or BRCA2 variants were analyzed for pathogenic variants in 10 other OC predisposing genes. Loss of heterozygosity analysis was performed on tumor DNA from variant carriers. Results: BRCA1 c.5407-25T>A intronic variant, identified in two affected sisters and one sporadic OC case, is predicted to create a new splice effecting transcription of BRCA1. WES data from BRCA1 c.5407-25T>A carriers showed no evidence of pathogenic variants in other OC predisposing genes. Sequencing the tumor DNA from the variant carrier showed complete loss of the wild-type allele. Conclusions: The findings support BRCA1 c.5407-25T>A as a likely pathogenic variant and highlight the importance of investigating intronic sequences as causal variants in OC families where the involvement of BRCA1 is highly suggestive.
Authors
Alenezi, WM; Fierheller, CT; Revil, T; Serruya, C; Mes-Masson, A-M; Foulkes, WD; Provencher, D; El Haffaf, Z; Ragoussis, J; Tonin, PNCollections
- Awaiting Allocation [233]
Language
Licence information
The following license files are associated with this item:
Related items
Showing items related by title, author, creator and subject.
-
A weighted burden test using logistic regression for integrated analysis of sequence variants, copy number variants and polygenic risk score.
Curtis, D (2019-01)Previously described methods of analysis allow variants in a gene to be weighted more highly according to rarity and/or predicted function and then for the variant contributions to be summed into a gene-wise risk score, ... -
Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes
Edghill, EL; Khamis, A; Weedon, MN; Walker, M; Hitman, GA; McCarthy, MI; Owen, KR; Ellard, S; Hattersley, AT; Frayling, TM (2011-06) -
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants
Luo, X; Feurstein, S; Mohan, S; Porter, CC; Jackson, SA; Keel, S; Chicka, M; Brown, AL; Kesserwan, C; Agarwal, A (2019-10-22)